Administration and implementation

  • Shake vigorously prior to use to obtain a homogenous, white suspension in the vaccine container
  • Do not use the vaccine if it cannot be suspended or if particulate matter or discoloration is found
  • For intramuscular use only
  • The preferred sites for injection are the anterolateral aspect of the thigh in infants and the deltoid muscle of the upper arm in toddlers and children. Do not inject in the gluteal area or areas where there may be a major nerve trunk and/or blood vessel
  • After being shipped, Prevnar 13® may arrive at temperatures between 2°C and 25°C (36°F and 77°F)
  • Store refrigerated at 2°C to 8°C (36°F to 46°F)
  • Prevnar 13® is stable at temperatures up to 25°C (77°F) for 4 days. These data are not recommendations for shipping or storage, but may guide decisions for use in case of temporary temperature excursions
  • Do not freeze (discard if vaccine has been frozen)
*At 2, 4, 6, and 12 to 15 months of age. In children 6 years through 17 years of age, Prevnar 13® is administered as a single dose.1
CDC=Centers for Disease Control and Prevention.